Circulation, Vol 87, 1067-1075, Copyright © 1993 by American Heart Association
D Waters, TE Craven and J Lesperance
BACKGROUND. Angiographic progression of coronary atherosclerosis is
frequently observed in clinical practice and is used as an end point in
clinical trials; however, its prognostic significance is unclear. METHODS
AND RESULTS. Progression defined as an increase in diameter stenosis by
> or = 15% of at least one coronary lesion was seen in 141 (42%) of 335
patients who underwent repeat coronary arteriography after a 2-year
interval as part of clinical trial. Coronary lesions were measured
quantitatively from comparable end-diastolic frames selected by a
radiologist viewing each pair of films together. During a mean follow-up of
44 +/- 10 months after the second arteriogram, cardiac death occurred in 19
patients (5.7%), cardiac death or nonfatal infarction was seen in 40 cases
(11.9%), and 90 patients (26.9%) underwent coronary revascularization. At
least one end point event occurred in 112 of the 335 patients. Sixteen of
the 19 cardiac deaths were in progressors, a relative risk of 7.3 (95% CI,
2.2-24.7; p < 0.001). The relative risk of cardiac death or nonfatal
infarction for progressors was 2.3 (1.3-4.2, p = 0.009) and of any cardiac
event was 1.7 (1.3-2.3, p < 0.001). A stepwise multivariable Cox
regression model of time to event was used to assess the relative
contribution of progression as a predictor of coronary events. Low ejection
fraction (p = 0.001), progression (p = 0.001), and hypertension (p = 0.011)
were retained as predictors of cardiac death. Angina and the number of
diseased vessels were the strongest predictors of revascularization.
CONCLUSIONS. Coronary progression is a strong, independent predictor of
future coronary events, particularly cardiac death, and its use as a
surrogate end point in clinical trials is justified.
ARTICLES
Prognostic significance of progression of coronary atherosclerosis
Department of Medicine, Montreal Heart Institute.
This article has been cited by other articles:
 |
|
 |
|
  C. M. Ballantyne, J. S. Raichlen, S. J. Nicholls, R. Erbel, J.-C. Tardif, S. J. Brener, V. A. Cain, S. E. Nissen, and for the ASTEROID Investigators Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden Circulation, May 13, 2008; 117(19): 2458 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J.P. Kastelein and E. de Groot Ultrasound imaging techniques for the evaluation of cardiovascular therapies Eur. Heart J., April 1, 2008; 29(7): 849 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Tardif, J. Gregoire, P. L. L'Allier, R. Ibrahim, J. Lesperance, T. M. Heinonen, S. Kouz, C. Berry, R. Basser, M.-A. Lavoie, et al. Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis: A Randomized Controlled Trial JAMA, April 18, 2007; 297(15): 1675 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Brown A Direct Comparison of Intravascular Ultrasound and Quantitative Coronary Arteriography: Implications for Measures of Atherosclerosis as Clinical Surrogates Circulation, April 10, 2007; 115(14): 1824 - 1826. [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Baron, T. S. Faber, A. Grom, T. Schwab, M. Brunner, A. Geibel, H. Just, C. Bode, and M. Zehender Real-time assessment of acute myocardial ischaemia by an intra-thoracic 6-lead ECG: evaluation of a new diagnostic option in the implantable defibrillator Europace, November 1, 2006; 8(11): 994 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Tardif, T. Heinonen, D. Orloff, and P. Libby Vascular Biomarkers and Surrogates in Cardiovascular Disease Circulation, June 27, 2006; 113(25): 2936 - 2942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Nissen, E. M. Tuzcu, H. B. Brewer, I. Sipahi, S. J. Nicholls, P. Ganz, P. Schoenhagen, D. D. Waters, C. J. Pepine, T. D. Crowe, et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N. Engl. J. Med., March 23, 2006; 354(12): 1253 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Nicholls, E. M. Tuzcu, I. Sipahi, P. Schoenhagen, T. Crowe, S. Kapadia, and S. E. Nissen Relationship Between Atheroma Regression and Change in Lumen Size After Infusion of Apolipoprotein A-I Milano J. Am. Coll. Cardiol., March 7, 2006; 47(5): 992 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schmermund, S. Achenbach, T. Budde, Y. Buziashvili, A. Forster, G. Friedrich, M. Henein, G. Kerkhoff, F. Knollmann, V. Kukharchuk, et al. Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months: A Multicenter, Randomized, Double-Blind Trial Circulation, January 24, 2006; 113(3): 427 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Clouse, J. Chen, H. M. Krumholz, M. E. Clouse, J. Chen, and H. M. Krumholz Noninvasive Screening for Coronary Artery Disease With Computed Tomography Is Useful Circulation, January 3, 2006; 113(1): 125 - 146. [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Mellen, W. T. Cefalu, and D. M. Herrington Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 189 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Madjid, A. Zarrabi, S. Litovsky, J. T. Willerson, and W. Casscells Finding Vulnerable Atherosclerotic Plaques: Is It Worth the Effort? Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1775 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Levy, P. Friedenberg, R. Lotan, P. Ouyang, M. Tripputi, L. Higginson, F. R. Cobb, J.-C. Tardif, V. Bittner, and B. V. Howard The Effect of Vitamin Therapy on the Progression of Coronary Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women Diabetes Care, April 1, 2004; 27(4): 925 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Nissen, E. M. Tuzcu, P. Schoenhagen, B. G. Brown, P. Ganz, R. A. Vogel, T. Crowe, G. Howard, C. J. Cooper, B. Brodie, et al. Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis: A Randomized Controlled Trial JAMA, March 3, 2004; 291(9): 1071 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. von Birgelen, M. Hartmann, G. S. Mintz, D. Baumgart, A. Schmermund, and R. Erbel Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed With Serial Long-Term (>=12 Months) Follow-Up Intravascular Ultrasound Circulation, December 2, 2003; 108(22): 2757 - 2762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Waters, E. L. Alderman, J. Hsia, B. V. Howard, F. R. Cobb, W. J. Rogers, P. Ouyang, P. Thompson, J. C. Tardif, L. Higginson, et al. Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women: A Randomized Controlled Trial JAMA, November 20, 2002; 288(19): 2432 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Jukema, Y. F. C. Smets, J. W. van der Pijl, A. H. Zwinderman, H. W. Vliegen, J. Ringers, J. H. C. Reiber, H. H. P. J. Lemkes, E. E. van der Wall, and J. W. de Fijter Impact of Simultaneous Pancreas and Kidney Transplantation on Progression of Coronary Atherosclerosis in Patients With End-Stage Renal Failure due to Type 1 Diabetes Diabetes Care, May 1, 2002; 25(5): 906 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Waters and P. Y. Hsue Low-Density-Lipoprotein Cholesterol Goals for Patients With Coronary Disease: Treating Between the Lines Circulation, November 27, 2001; 104(22): 2635 - 2637. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Schwartz and M. G. Bourassa Evaluation of Patients With Chest Pain and Normal Coronary Angiograms Arch Intern Med, August 13, 2001; 161(15): 1825 - 1833. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Herrington, D. M. Reboussin, K. B. Brosnihan, P. C. Sharp, S. A. Shumaker, T. E. Snyder, C. D. Furberg, G. J. Kowalchuk, T. D. Stuckey, W. J. Rogers, et al. Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis N. Engl. J. Med., August 24, 2000; 343(8): 522 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Waters and R. R. Azar Postscripts From the Post Coronary Artery Bypass Graft Trial : The Sustained Benefit of More Aggressive Cholesterol Lowering and the Enigma of Low-Dose Anticoagulation Circulation, July 11, 2000; 102(2): 144 - 146. [Full Text] [PDF]
|
|
|
|
|
|
G. L. Knatterud, Y. Rosenberg, L. Campeau, N. L. Geller, D. B. Hunninghake, S. A. Forman, J. S. Forrester, F. L. Gobel, J. A. Herd, A. Hickey, et al. Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial Circulation, July 11, 2000; 102(2): 157 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. U. Gerdes, C. Gerdes, K. Kervinen, M. Savolainen, I. C. Klausen, P. S. Hansen, Y. A. Kesaniemi, and O. Fargeman The Apolipoprotein {epsilon}4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction : A Substudy of the Scandinavian Simvastatin Survival Study Circulation, March 28, 2000; 101(12): 1366 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mehran, G. Dangas, G. S. Mintz, A. J. Lansky, A. D. Pichard, L. F. Satler, K. M. Kent, G. W. Stone, and M. B. Leon Atherosclerotic Plaque Burden and CK-MB Enzyme Elevation After Coronary Interventions : Intravascular Ultrasound Study of 2256 Patients Circulation, February 15, 2000; 101(6): 604 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Mann and M J Davies Mechanisms of progression in native coronary artery disease: role of healed plaque disruption Heart, September 1, 1999; 82(3): 265 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yokoya, H. Takatsu, T. Suzuki, H. Hosokawa, S. Ojio, T. Matsubara, T. Tanaka, S. Watanabe, N. Morita, K. Nishigaki, et al. Process of Progression of Coronary Artery Lesions From Mild or Moderate Stenosis to Moderate or Severe Stenosis : A Study Based on Four Serial Coronary Arteriograms per Year Circulation, August 31, 1999; 100(9): 903 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J W. JUKEMA Matching treatment to the genetic basis of (lipid) disorder in patients with coronary artery disease Heart, August 1, 1999; 82(2): 126 - 127. [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. KEANEY JR., D. I. SIMON, and J. E. FREEDMAN Vitamin E and vascular homeostasis: implications for atherosclerosis FASEB J, June 1, 1999; 13(9): 965 - 975. [Abstract] [Full Text]
|
|
|
|
|
|
A. Zambon, J. E. Hokanson, B. G. Brown, and J. D. Brunzell Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression : Hepatic Lipase–Mediated Changes in LDL Density Circulation, April 20, 1999; 99(15): 1959 - 1964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ledru, P. Theroux, J. Lesperance, J. Laurier, P. Ducimetiere, J.-L.e. Guermonprez, B. Diebold, and D. Blanchard Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1353 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Ballantyne, J. A. Herd, L. L. Ferlic, J. K. Dunn, J. A. Farmer, P. H. Jones, J. R. Schein, and A. M. Gotto Jr Influence of Low HDL on Progression of Coronary Artery Disease and Response to Fluvastatin Therapy Circulation, February 16, 1999; 99(6): 736 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Vogel and M. C. Corretti Estrogens, Progestins, and Heart Disease : Can Endothelial Function Divine the Benefit? Circulation, April 7, 1998; 97(13): 1223 - 1226. [Full Text] [PDF]
|
|
|
|
|
|
W. H. F. Sutherland, N. J. Restieaux, E. R. Nye, M. J. A. Williams, S. A. de Jong, M. C. Robertson, and H. L. Walker IDL Composition and Angiographically Determined Progression of Atherosclerotic Lesions During Simvastatin Therapy Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 577 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Kuivenhoven, J. W. Jukema, A. H. Zwinderman, P. de Knijff, R. McPherson, A. V.G. Bruschke, K. I. Lie, J. J.P. Kastelein, and The Regression Growth Evaluation Statin Study Grou The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis N. Engl. J. Med., January 8, 1998; 338(2): 86 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Jukema, A. J. van Boven, B. Groenemeijer, A. H. Zwinderman, J. H.C. Reiber, A. V.G. Bruschke, J.A. Henneman, G.P. Molhoek, T. Bruin, H. Jansen, et al. The Asp9 Asn Mutation in the Lipoprotein Lipase Gene Is Associated With Increased Progression of Coronary Atherosclerosis Circulation, October 15, 1996; 94(8): 1913 - 1918. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Davies Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995 Circulation, October 15, 1996; 94(8): 2013 - 2020. [Full Text]
|
|
|
|
|
|
L. Wexler, B. Brundage, J. Crouse, R. Detrano, V. Fuster, J. Maddahi, J. Rumberger, W. Stanford, R. White, and K. Taubert Coronary Artery Calcification: Pathophysiology, Epidemiology, Imaging Methods, and Clinical Implications: A Statement for Health Professionals From the American Heart Association Circulation, September 1, 1996; 94(5): 1175 - 1192. [Full Text]
|
|
|
|
|
|
D. Waters, J. Lesperance, P. Gladstone, S. J. Boccuzzi, T. Cook, R. Hudgin, G. Krip, and L. Higginson Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy Circulation, August 15, 1996; 94(4): 614 - 621. [Abstract] [Full Text]
|
|
|
|
|
|
J. W. Jukema, A. H. Zwinderman, A. J. van Boven, J. H.C. Reiber, A. Van der Laarse, K. I. Lie, and A. V.G. Bruschke Evidence for a Synergistic Effect of Calcium Channel Blockers With Lipid-Lowering Therapy in Retarding Progression of Coronary Atherosclerosis in Symptomatic Patients With Normal to Moderately Raised Cholesterol Levels Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 425 - 430. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Espeland, T. E. Craven, W. A. Riley, J. Corson, A. Romont, and C. D. Furberg Reliability of Longitudinal Ultrasonographic Measurements of Carotid Intimal-Medial Thicknesses Stroke, March 1, 1996; 27(3): 480 - 485. [Abstract] [Full Text]
|
|
|
|
|
|
S. P. Azen, W. J. Mack, L. Cashin-Hemphill, L. LaBree, A. M. Shircore, R. H. Selzer, D. H. Blankenhorn, and H. N. Hodis Progression of Coronary Artery Disease Predicts Clinical Coronary Events : Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study Circulation, January 1, 1996; 93(1): 34 - 41. [Abstract] [Full Text]
|
|
|
|
|
|
D. Waters, L. Higginson, P. Gladstone, S. J. Boccuzzi, T. Cook, and J. Lesperance Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in Women : A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy Circulation, November 1, 1995; 92(9): 2404 - 2410. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Ozaki, D. Keane, and P. W. Serruys Progression and Regression of Coronary Stenosis in the Long-term Follow-up of Vasospastic Angina Circulation, November 1, 1995; 92(9): 2446 - 2456. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Kaski, M. R. Chester, L. Chen, and D. Katritsis Rapid Angiographic Progression of Coronary Artery Disease in Patients With Angina Pectoris : The Role of Complex Stenosis Morphology Circulation, October 15, 1995; 92(8): 2058 - 2065. [Abstract] [Full Text]
|
|
|
|
|
|
E. Falk, P. K. Shah, and V. Fuster Coronary Plaque Disruption Circulation, August 1, 1995; 92(3): 657 - 671. [Full Text]
|
|
|
|
|
|
R. J. Havel and E. Rapaport Management of Primary Hyperlipidemia N. Engl. J. Med., June 1, 1995; 332(22): 1491 - 1498. [Full Text] [PDF]
|
|
|
|
|
|
G. N. Levine, J. F. Keaney, and J. A. Vita Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521. [Full Text] [PDF]
|
|
|
|
|
|
W. S. Weintraub, S. J. Boccuzzi, J. L. Klein, A. S. Kosinski, S. B. King, R. Ivanhoe, J. C. Cedarholm, M. E. Stillabower, J. D. Talley, S. J. DeMaio, et al. Lack of Effect of Lovastatin on Restenosis after Coronary Angioplasty N. Engl. J. Med., November 17, 1994; 331(20): 1331 - 1337. [Abstract] [Full Text]
|
|